Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2003
12/31/2003WO2004000237A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists
12/31/2003WO2004000205A2 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
12/31/2003WO2003069303A3 Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof
12/31/2003WO2003059269A3 Acridone inhibitors of impdh enzyme
12/31/2003CN1463974A Method for preparation of Triazolo pyrimidine derivative
12/31/2003CN1132819C 作为TNF－α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors
12/31/2003CA2490526A1 Hetero-bicyclic compounds
12/31/2003CA2490124A1 Scaffolded maleimide clusters for multivalent peptide assembly
12/31/2003CA2490109A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
12/31/2003CA2490108A1 Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof
12/31/2003CA2490082A1 Quinuclidine derivatives and pharmaceutical compositions containing the same
12/31/2003CA2487544A1 Pyrazolopyrimidines
12/31/2003CA2464539A1 Enhancing treatment of mdr cancer with adenosine a3 antagonists
12/31/2003CA2445515A1 Transcription factor modulating compounds and methods of use thereof
12/30/2003US6670447 Amino acid N-carboxyanhydrides with acyl substituents on nitrogen atoms thereof
12/30/2003US6670386 For therapy of nuclear hormone receptor-associated conditions, such as age related diseases, for example sarcopenia
12/30/2003US6670366 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
12/30/2003US6670365 Substituted imidazo 1,2a}azines as selective inhibitors of cox-2
12/30/2003US6670360 Antiulcer, antibacterial activity against Helicobacter pylori
12/30/2003US6670357 Antiinflammatory agents
12/30/2003US6670354 Methods to enhance white blood cell count
12/30/2003CA2293621C 4-aminopyrrole(3,2-d) pyrimidines as neuropeptide y receptor antagonists
12/30/2003CA2215727C Hybrid phthalocyanine derivatives and their uses
12/30/2003CA2051399C Therapeutically useful 2-aminotetralin derivatives
12/25/2003US20030236438 Enantioselective 1,4-addition of aromatic nucleophiles to alpha,beta-unsaturated aldehydes using chiral organic catalysts
12/25/2003US20030236406 Amination forming a benzylammonium methyl phenoxy 5-tetrahydrobenzothiepine; apical sodium co- dependent bile acid transporter inhibitors, anticholesterol agents
12/25/2003US20030236405 7-hetero-bicyclo[2.2.1]-heptanes
12/25/2003US20030236402 A caspase-3 enzyme inhibitors, 3-(3-alkyl-amino-2-oxo-1,2-dihydro-1-pyrazinyl-alkanoylamino) -4-oxopentanoic acid; treating cardiac or cerebral ischemia or reperfusion injury, diabetes, AIDS
12/25/2003US20030236400 A metal porphyrin compounds or complexes, use as sensitizers in photodynamic therapy
12/25/2003US20030236296 Novel interleukin-1beta converting enzyme inhibitors
12/25/2003US20030236279 Central nervous system disorders; psychological disorders
12/25/2003US20030236270 Central nervous system disorders
12/25/2003US20030236263 Chemical compounds
12/25/2003US20030236262 Dietetics; antidiabetic agents; sexual disorders
12/25/2003US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins
12/25/2003US20030236245 Helix mimetics and composition and methods related thereto
12/25/2003US20030235513 Optical oxygen concentration measurement method and optical oxygen concentration measuring sensor
12/25/2003US20030234379 Dicationic viologens, such as methyl viologen and benzyl viologen, associated with anions selected from bis(trifluoro-methyl(or perfluoroethyl)sulfonyl)imide and tris(trifluoro-methylsulfonyl)methide; soluble in quat ammonium melts
12/24/2003WO2003106460A1 Novel interleukin-1 beta converting enzyme inhibitors
12/24/2003WO2003106450A1 Phenylaminopyrimidines and their use as rho-kinase inhibitors
12/24/2003WO2003106425A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity
12/24/2003WO2003105770A2 Carbocyclic nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
12/24/2003WO2003095455A3 Substituted pyrazolopyrimidines
12/24/2003WO2003053361A3 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE
12/24/2003WO2002085901A8 Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor agonists)
12/24/2003WO2002066037A8 Antiviral method of use
12/24/2003CN1463270A Disulfide prodrugs and linkers and stablizers useful therefore
12/24/2003CN1131866C Mempalon hemotoidin and mampalon haem and their preparing method
12/24/2003CN1131865C 作为选择性COX－2抑制剂的取代的咪唑并[1,2a]吖嗪 Substituted imidazole as selective COX-2 inhibitors and [1,2a] azines
12/24/2003CA2488842A1 Carbocyclic nucleoside analogs as rna-antivirals
12/23/2003US6667398 Reacting a benzamidine compound with a amide substituted pyrazole compound
12/23/2003US6667316 Pharmaceutically active isoindoline derivatives
12/23/2003US6667312 Thioether substituted imidazoquinolines
12/23/2003US6667304 Affinity for melatonin receptors; sleep disorders; N-(2-(2-methoxy-6H-pyrido(2',3':4,5)pyrrolo(2,1-a)isoindol-11 -yl)ethyl)acetamide; N-(2-(3-methoxy-6,7,8,9-tetrahydropyrido (3,2-b)indolizin-5-yl) ethyl)acetamide
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/23/2003US6667300 Purinyl substituted quinazoline-4-one derivatives
12/20/2003CA2424443A1 Chlorin and bacteriochlorin-based difunctional aminophenyl dtpa and n2s2 conjugates for mr contrast media and radiopharmaceuticals
12/18/2003WO2003105538A1 Electroluminescent device
12/18/2003WO2003105237A1 Synthesis of perylene-porphyrin building blocks and polymers thereof for the production of light-harvesting arrays
12/18/2003WO2003104237A1 2,7,12,17 alkenyl, aryl and heteroaryl derived from 3,6,13,16-tetraazaporphycene, method, intermediate compound and corresponding utilizations
12/18/2003WO2003104236A1 Calcitonin gene related peptide receptor antagonists
12/18/2003WO2003104235A1 Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]pyrazines and decahydropyrazino[1,2-a]azepines
12/18/2003WO2003104231A1 NOVEL INTERLEUKIN-1beta CONVERTING ENZYME INHIBITORS
12/18/2003WO2003104229A1 Novel fused imidazole derivative
12/18/2003WO2003104208A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003104207A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003103680A1 Substituted porphyrins
12/18/2003WO2003103669A1 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists
12/18/2003WO2003103590A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
12/18/2003WO2003103575A2 Compounds, compositions, and methods
12/18/2003WO2003103574A2 Protease inhibitors
12/18/2003WO2003082817A3 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/18/2003WO2003057149A3 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones
12/18/2003WO2003051795A3 Resin-bonded isonitriles
12/18/2003WO2003044021A3 Substituted indolizine-like compounds and methods of use
12/18/2003WO2003022804A9 Method for the preparation of crystalline tetrahydrobenzothiepines
12/18/2003WO2002060871A8 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor
12/18/2003WO2002057492A9 Methods and compositions for detecting polynucleotide duplex damage
12/18/2003WO2002014536A9 Odulating multiple lineage kinase proteins
12/18/2003US20030232982 Method to prepare porphyrin nanoparticles and its application as oxidation catalyst
12/18/2003US20030232853 Azabicyclic compounds for the treatment of disease
12/18/2003US20030232847 Imidazo-substituted compounds as p38 kinase inhibitors
12/18/2003US20030232838 6-phenylpyrrolopyrimidinedione derivatives
12/18/2003US20030232832 Nitrogen compounds such as N-(3-Aminopropyl)-N-(1-(3-benzyl-4 -oxo-3,4-dihydropyrrolo(2,1-f)(1,2,4)-triazine-2-yl)-propyl)-4 -methylbenzamide, trifluoroacetic acid salt, used as anticarcinogenic or antiproliferative agents
12/18/2003US20030232831 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
12/18/2003US20030232826 Amidino and guanidino peptidyl compounds
12/18/2003US20030232821 Oxadiazine derivatives
12/18/2003US20030232817 Small molecules useful for the treatment of inflammatory disease
12/18/2003US20030232800 Non-symmetric tripyrranes in the synthesis of novel macrocycles
12/18/2003US20030232794 Fused nitrogen heterocycle derivatives useful to inhibit cancer or sensitize cancer cells to chemotherapeutic agents, radiation or other anti-cancer treatments
12/18/2003US20030229949 Hair dyes; fast coloration of keratin fibers
12/18/2003CA2488567A1 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
12/18/2003CA2488500A1 Substituted porphyrins
12/18/2003CA2487430A1 Electroluminescent device
12/17/2003EP1371647A2 Pyridine-3-carboxylic acid derivatives and their use as intermediates
12/17/2003EP1370568A1 Chemical compounds
12/17/2003EP1370562A1 Thieno[2,3-d]pyrimidindione derivatives as matrix metalloproteinase inhibitors
12/17/2003EP1370561A2 Tetrahydro-pyrazino[1,2-a]indoles for the treatment of central nervous disorders
12/17/2003EP1370560A1 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists
12/17/2003EP1370557A1 Benzimidazole anti-inflammatory compounds
1 ... 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 ... 573